XTL Biopharmaceuticals Sponsored ADR (HHB0) Q2 2018 Earnings Report
DE:HHB0 Q2 2018 EPS Results
- Actual EPS
- EUR 0.01
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.26
DE:HHB0 Q2 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 07/24/2018
- Time
- Before Open
- Conference Call
- Tuesday, July 24, 2018
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:HHB0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 05, 2023 | 2023 (Q3) | ―-0.03 | -0.13 | 74.17% (+0.10) | |
| May 31, 2023 | 2023 (Q1) | ―-0.15 | 0.08 | -281.72% (-0.23) | |
| Dec 06, 2022 | 2022 (Q3) | ―-0.13 | -0.13 | 0.00% (+0.00) | |
| Nov 24, 2021 | 2021 (Q3) | ―-0.13 | -0.1 | -31.30% (-0.03) | |
| May 19, 2021 | 2021 (Q1) | ―0.05 | 0 | 980.00% (+0.04) | |
| Jul 24, 2018 | 2018 (Q2) | ―0.01 | -0.26 | 102.33% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed